iCAD Inc. (ICAD)

3.03
0.04 1.30
NASDAQ : Electronic Technology
Prev Close 2.99
Open 2.98
Day Low/High 2.98 / 3.09
52 Wk Low/High 2.80 / 4.89
Volume 13.48K
Avg Volume 38.80K
Exchange NASDAQ
Shares Outstanding 16.86M
Market Cap 48.06M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
ICAD Reports 2013 Fourth Quarter And Full Year Financial Results

ICAD Reports 2013 Fourth Quarter And Full Year Financial Results

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial...

ICAD To Host 2013 Fourth Quarter And Full Year Financial Results Conference Call On Thursday, February 20, 2014

ICAD To Host 2013 Fourth Quarter And Full Year Financial Results Conference Call On Thursday, February 20, 2014

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, today announced that the Company...

ICAD To Participate In The 16th Annual Needham Growth Conference

ICAD To Participate In The 16th Annual Needham Growth Conference

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announces that Company management will...

3 Stocks Spiking on Big Volume

3 Stocks Spiking on Big Volume

Unusual volume can signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

ICAD To Participate In The LD Micro Conference

ICAD To Participate In The LD Micro Conference

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announces that Company management will...

ICAD To Showcase Its Platform Of Computer-Aided Detection And Advanced Imaging Solutions At RSNA Annual Meeting

ICAD To Showcase Its Platform Of Computer-Aided Detection And Advanced Imaging Solutions At RSNA Annual Meeting

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company ...

ICAD Promotes CFO Kevin Burns To Chief Operating Officer

ICAD Promotes CFO Kevin Burns To Chief Operating Officer

iCAD, Inc. (Nasdaq:ICAD), industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that Chief ...

ICAD Reports Growing Adoption And Utilization Of Its Xoft System For Breast And Skin Cancers

ICAD Reports Growing Adoption And Utilization Of Its Xoft System For Breast And Skin Cancers

iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced imaging and radiation therapy for the early identification and treatment of cancer, today announced growing demand, adoption and clinical evidence for its Xoft®...

ICAD To Participate In The Canaccord Genuity Medical Technology & Diagnostics Forum

ICAD To Participate In The Canaccord Genuity Medical Technology & Diagnostics Forum

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announces that Company management will...

ICAD Reports Third Quarter Financial Results

ICAD Reports Third Quarter Financial Results

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial...

ICAD To Host Third Quarter Financial Results Conference Call On Tuesday, October 29, 2013

ICAD To Host Third Quarter Financial Results Conference Call On Tuesday, October 29, 2013

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company will...

First Week Of June 2014 Options Trading For ICAD

First Week Of June 2014 Options Trading For ICAD

Investors in iCAD inc saw new options begin trading this week, for the June 2014 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

ICAD Announces Positive Three-Year Data Using The Xoft System To Treat Skin Cancer Presented At ASTRO

ICAD Announces Positive Three-Year Data Using The Xoft System To Treat Skin Cancer Presented At ASTRO

– Booth Number 2449 – iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer,...

ICAD To Participate In Craig-Hallum’s 4th Annual Alpha Select Conference

ICAD To Participate In Craig-Hallum’s 4th Annual Alpha Select Conference

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that Company ...

ICAD To Highlight Xoft System To Treat Skin, Breast And Gynecological Cancers At ASTRO

ICAD To Highlight Xoft System To Treat Skin, Breast And Gynecological Cancers At ASTRO

ASTRO Booth Number 2449-- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today...

ICAD’s Strategic Partnership With Advanced Rad Solutions Expands Availability Of The Xoft System Into Dermatology Centers

ICAD’s Strategic Partnership With Advanced Rad Solutions Expands Availability Of The Xoft System Into Dermatology Centers

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced a strategic ...

ICAD Expands Access To The Xoft System For Treating Non-Melanoma Skin Cancer To Dermatology Centers Via A Strategic Alliance With DermEbx

ICAD Expands Access To The Xoft System For Treating Non-Melanoma Skin Cancer To Dermatology Centers Via A Strategic Alliance With DermEbx

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced a strategic ...

ICAD Reports Second Quarter Financial Results

ICAD Reports Second Quarter Financial Results

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial...

ICAD To Host Second Quarter Financial Results Conference Call On Tuesday, July 30, 2013

ICAD To Host Second Quarter Financial Results Conference Call On Tuesday, July 30, 2013

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company will...

ICAD To Join The Russell Microcap® Index

ICAD To Join The Russell Microcap® Index

iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced imaging and radiation therapy technologies for the detection and treatment of cancer, today announced that the Company will join the Russell Microcap ® ...

ICAD Receives FDA Approval For FujiFilm Aspire HD Digital Mammography System

ICAD Receives FDA Approval For FujiFilm Aspire HD Digital Mammography System

iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced approval by...

ICAD Announces FDA Clearance Of Cervical Applicator For Xoft Electronic Brachytherapy System

ICAD Announces FDA Clearance Of Cervical Applicator For Xoft Electronic Brachytherapy System

iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced imaging and radiation therapy technologies for the detection and treatment of cancer, today announced that the company received U.

ICAD And Invivo Announce Global Strategic Agreement To Deliver MRI Solutions Worldwide

ICAD And Invivo Announce Global Strategic Agreement To Deliver MRI Solutions Worldwide

Invivo, a Philips Healthcare Business, and a worldwide leader in MRI, and iCAD, Inc.

ICAD Reports Fourth Quarter And Full Year 2012 Financial Results

ICAD Reports Fourth Quarter And Full Year 2012 Financial Results

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial...

ICAD To Host Fourth Quarter And Full Year 2012 Financial Results Conference Call On Wednesday, February 20, 2013

ICAD To Host Fourth Quarter And Full Year 2012 Financial Results Conference Call On Wednesday, February 20, 2013

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company will...

ICAD, Inc. To Present At 15th Annual Needham & Company Growth Conference

ICAD, Inc. To Present At 15th Annual Needham & Company Growth Conference

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announced today that Ken Ferry, ...

ICAD Receives FDA Approval For Digital CAD With Philips Digital Mammography System

ICAD Receives FDA Approval For Digital CAD With Philips Digital Mammography System

iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced approval by...

ICAD Launches New VersaVue MR Software At RSNA 2012

ICAD Launches New VersaVue MR Software At RSNA 2012

iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the identification and treatment of cancer, announced today it will launch...

New Italian Study Uses ICAD’s SecondLook Digital Mammography CAD Software

New Italian Study Uses ICAD’s SecondLook Digital Mammography CAD Software

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announced today it has provided...

ICAD Reports Significantly Improved Medicare Payment For Intraoperative Radiation Therapy

ICAD Reports Significantly Improved Medicare Payment For Intraoperative Radiation Therapy

iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced imaging and radiation therapy for the early identification and treatment of cancer, today announced the U.

TheStreet Quant Rating: D (Sell)